News
News
Local News
Crime & Public Safety
Your Tax Dollars At Work
Politics
Massachusetts
Nation
World
Business
Health
Weather
Columnists
Traffic
Sports
Sports
Red Sox
Patriots
Celtics
Bruins
College
High School
More Sports
Scores & Stats
Entertainment
Entertainment
Celebrity News
Arts & Culture
Movies
Television
Music
Fun & Games
Horoscope
Lottery
Comics
Puzzles
Lifestyle
Lifestyle
Food & Beverage
Travel
Style & Fashion
Obituaries
Obituaries
Local Obituaries
Submit an Obituary
Opinion
Opinion
Editorials
Op-Ed
Letters
Submit a Letter
Radio
Weather
E-Edition
Subscribe
Sign Up For Newsletters
News
News
Local News
Crime & Public Safety
Your Tax Dollars At Work
Politics
Massachusetts
Nation
World
Business
Health
Weather
Columnists
Traffic
Sports
Sports
Red Sox
Patriots
Celtics
Bruins
College
High School
More Sports
Scores & Stats
Entertainment
Entertainment
Celebrity News
Arts & Culture
Movies
Television
Music
Fun & Games
Horoscope
Lottery
Comics
Puzzles
Lifestyle
Lifestyle
Food & Beverage
Travel
Style & Fashion
Obituaries
Obituaries
Local Obituaries
Submit an Obituary
Opinion
Opinion
Editorials
Op-Ed
Letters
Submit a Letter
Radio
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Glaukos Corporation
< Previous
1
2
Next >
Glaukos Announces Participation in Upcoming Investor Conferences
August 16, 2024
From
Glaukos Corporation
Via
Business Wire
Tickers
GKOS
Glaukos Announces Second Quarter 2024 Financial Results
July 31, 2024
From
Glaukos Corporation
Via
Business Wire
Tickers
GKOS
Glaukos to Release Second Quarter 2024 Financial Results after Market Close on July 31
July 10, 2024
From
Glaukos Corporation
Via
Business Wire
Tickers
GKOS
Glaukos Announces Agreements to Exchange $230 Million in Principal Amount of Its 2.75% Convertible Senior Notes Due 2027 for Common Stock
June 14, 2024
From
Glaukos Corporation
Via
Business Wire
Tickers
GKOS
Glaukos Announces Participation in Upcoming Investor Conferences
May 28, 2024
From
Glaukos Corporation
Via
Business Wire
Tickers
GKOS
Glaukos Announces First Quarter 2024 Financial Results
May 01, 2024
From
Glaukos Corporation
Via
Business Wire
Tickers
GKOS
Glaukos Announces the Release of its 2023 Sustainability Report
April 16, 2024
From
Glaukos Corporation
Via
Business Wire
Tickers
GKOS
Glaukos to Release First Quarter 2024 Financial Results after Market Close on May 1
April 10, 2024
From
Glaukos Corporation
Via
Business Wire
Tickers
GKOS
Glaukos Receives Permanent J-code for iDose® TR (travoprost intracameral implant)
April 03, 2024
From
Glaukos Corporation
Via
Business Wire
Tickers
GKOS
Glaukos To Present Numerous Scientific Abstracts at the 2024 American Society of Cataract and Refractive Surgery Annual Meeting
April 01, 2024
From
Glaukos Corporation
Via
Business Wire
Tickers
GKOS
Glaukos Announces Fourth Quarter and Full Year 2023 Financial Results
February 21, 2024
From
Glaukos Corporation
Via
Business Wire
Tickers
GKOS
Glaukos to Release Fourth Quarter and Full Year 2023 Financial Results after Market Close on February 21
January 31, 2024
From
Glaukos Corporation
Via
Business Wire
Tickers
GKOS
Glaukos Announces Preliminary, Unaudited Fourth Quarter and Full Year 2023 Net Sales and Reaffirms 2024 Revenue Guidance
January 09, 2024
From
Glaukos Corporation
Via
Business Wire
Tickers
GKOS
Glaukos Announces Participation in the J.P. Morgan Healthcare Conference
December 20, 2023
From
Glaukos Corporation
Via
Business Wire
Tickers
GKOS
Glaukos Announces FDA Approval of iDose® TR (travoprost intracameral implant)
December 14, 2023
From
Glaukos Corporation
Via
Business Wire
Tickers
GKOS
Glaukos Announces Participation in Stifel Healthcare Conference
November 07, 2023
From
Glaukos Corporation
Via
Business Wire
Tickers
GKOS
Glaukos Announces Third Quarter 2023 Financial Results
November 01, 2023
From
Glaukos Corporation
Via
Business Wire
Tickers
GKOS
Glaukos Technologies Featured in Numerous Scientific Abstracts at the 2023 American Academy of Ophthalmology Annual Meeting
October 31, 2023
From
Glaukos Corporation
Via
Business Wire
Tickers
GKOS
Glaukos to Release Third Quarter 2023 Financial Results after Market Close on November 1, 2023
October 11, 2023
From
Glaukos Corporation
Via
Business Wire
Tickers
GKOS
Glaukos Announces Participation in Wells Fargo Healthcare Conference
August 23, 2023
From
Glaukos Corporation
Via
Business Wire
Tickers
GKOS
Glaukos Announces Second Quarter 2023 Financial Results
August 02, 2023
From
Glaukos Corporation
Via
Business Wire
Tickers
GKOS
Glaukos Enters into a Collaboration and Marketing Agreement with Radius XR, Inc.
July 17, 2023
From
Glaukos Corporation
Via
Business Wire
Tickers
GKOS
Glaukos to Release Second Quarter 2023 Financial Results after Market Close on August 2, 2023
July 12, 2023
From
Glaukos Corporation
Via
Business Wire
Tickers
GKOS
Glaukos Achieves Pipeline Milestone with Enrollment Completion in Phase 3 Confirmatory Trial for Epioxa (Epi-on)
June 05, 2023
From
Glaukos Corporation
Via
Business Wire
Tickers
GKOS
Glaukos Announces Participation in the William Blair Growth Stock Conference
May 24, 2023
From
Glaukos Corporation
Via
Business Wire
Tickers
GKOS
Glaukos Announces FDA Acceptance of NDA Submission for iDose TR
May 05, 2023
From
Glaukos Corporation
Via
Business Wire
Tickers
GKOS
Glaukos Announces First Quarter 2023 Financial Results
May 03, 2023
From
Glaukos Corporation
Via
Business Wire
Tickers
GKOS
Glaukos Technologies Featured in Numerous Scientific Abstracts at the 2023 American Society of Cataract and Refractive Surgery Annual Meeting
May 01, 2023
From
Glaukos Corporation
Via
Business Wire
Tickers
GKOS
Glaukos Announces the Release of its 2022 Sustainability Report
April 19, 2023
From
Glaukos Corporation
Via
Business Wire
Tickers
GKOS
Glaukos to Release First Quarter 2023 Financial Results after Market Close on May 3
April 12, 2023
From
Glaukos Corporation
Via
Business Wire
Tickers
GKOS
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Close